1-乙氧基-4-(甲氧基甲基)苯 | 103441-19-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-乙氧基-4-(甲氧基甲基)苯
• 英文名称: 1-ethoxy-4-(methoxymethyl)benzene
• 英文别名: 1-ethoxy-4-methoxymethyl-benzene；1-Aethoxy-4-methoxymethyl-benzol
• CAS: 103441-19-6
• 化学式: C₁₀H₁₄O₂
• mdl: MFCD09749820
• 分子量: 166.22
• InChiKey: QZMZUIGZTVFXKD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  sodium methylate 、 1-氯甲基-4-乙氧基苯 在 甲醇 作用下， 生成 1-乙氧基-4-(甲氧基甲基)苯
  参考文献：
  名称：

  Asojan et al., Nauchnye Trudy, Erevanskii Gosudarstvennyi Universitet, Seriya Khimicheskikh Nauk, 1956, vol. 53, p. 53

  摘要：

  DOI：

文献信息

• 6,5-Fused bicyclic heterocycles
  申请人：——

  公开号：US20040014759A1

  公开（公告）日：2004-01-22

  The present invention provides compounds of Formula (I) wherein Q 1 , Q 2 , Q 3 , Q 4 , Y 1 , Y 2 , and Z are as defined in the description, and pharmaceutically acceptable salts thereof, and C 1 -C 8 alkyl esters thereof, which are useful for the treatment of diseases responsive to the inhibition of the enzyme 15-lipoxygenase. Thus, the compounds of Formula (I) and their pharmaceuticalyl acceptable salts are useful for treating diseases with an inflammatory component, including atherosclerosis, diseases involving chemotaxis of monocytes, inflammation, stroke, coronary artery disease, asthma, arthritis, colorectal cancer, and psoriasis. 1

  本发明提供了Formula (I)中的化合物，其中Q1、Q2、Q3、Q4、Y1、Y2和Z如描述中定义，并且其药用盐和C1-C8烷基酯，这些化合物对于治疗对15-脂氧合酶抑制有响应的疾病是有用的。因此，Formula (I)中的化合物及其药用盐对于治疗具有炎症成分的疾病是有用的，包括动脉粥样硬化、涉及单核细胞趋化、炎症、中风、冠状动脉疾病、哮喘、关节炎、结直肠癌和银屑病。
• 5-Amide substituted diarylamines as mex inhibitors
  申请人：——

  公开号：US20030225076A1

  公开（公告）日：2003-12-04

  Diarylanines, such as 5-amide substituted diarylamines of formula (I) or formula (II) wherein A is hydroxy, C 1-6 alkoxy, or NR 6 OR 7 ; X is OR 12 , NR 13 R 12 , or NR 14 ; inhibitors of MEK and are useful in the treatment of a variety of proliferative disease states, such as conditions related to the hyperactivity of MEK, as well as diseases modulated by the MEK cascade.

  Diarylanines，例如式（I）或式（II）中的5-酰胺取代的二芳胺，其中A是羟基、C1-6烷氧基或NR6OR7；X是OR12、NR13R12或NR14；MEK的抑制剂，在治疗各种增殖性疾病状态方面非常有用，例如与MEK过度活跃有关的疾病，以及由MEK级联调节的疾病。
• Direct synthesis of ethers from aldehydes and ketones. One-pot reductive etherification of benzaldehydes, alkyl aryl ketones, and benzophenones
  作者：S. S. Mochalov、A. N. Fedotov、E. V. Trofimova、N. S. Zefirov

  DOI：10.1134/s1070428016040047

  日期：2016.4

  Benzyl alcohols formed by the reduction of benzaldehydes, alkyl aryl ketones, and benzophenones with sodium tetrahydridoborate in alcohols undergo in situ etherification with the solvent in the presence of a catalytic amount of HCl. Thus the process may be regarded as one-pot transformation of carbonyl compounds into the corresponding benzyl ethers. The yields of ethers depend on the substituent nature

  通过在醇中催化量的四氢硼酸钠将苯甲醛，烷基芳基酮和二苯甲酮还原而形成的苄醇在催化量的HCl的存在下与溶剂进行原位醚化。因此，该方法可以被认为是羰基化合物一锅转化为相应的苄基醚。醚的产率取决于初始羰基化合物的芳族片段中的取代基性质以及用作还原介质的醇。
• Methods for preparing P2X7 inhibitors
  申请人：Li Bryan Zhengong

  公开号：US20050288256A1

  公开（公告）日：2005-12-29

  The present invention relates to the methods for preparing compounds of the formula I: or the pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 4 , R 10 , and R 11 have any of the values defined in the specification. The compounds of the present invention are useful in the treatment of diseases, including inflammatory diseases such as rheumatoid arthritis.

  本发明涉及制备以下化合物的方法：或其在药学上可接受的盐，其中R1、R2、R4、R10和R11具有规范中定义的任一值。本发明的化合物在治疗疾病方面具有用途，包括类风湿性关节炎等炎症性疾病。
• Indole and benzimidazole 15-lipoxygenase inhibitors
  申请人：——

  公开号：US20040038943A1

  公开（公告）日：2004-02-26

  This invention provides indole and benzimidazole 15-lipoxygenase (15-LO) inhibitors of the formula where one of Y 1 and Y 2 is CH, N, or NH, and the other is R 3 includes H, halo. HN 2 , COOH, alkyl; R 4 includes halo, alkyl, and alkoxy; Z is C, CH, or NR 5 ; R 5 is H or oxycabonyl; and each X is independently H, alkyl, alkoxy, or halo. 1

  这项发明提供了一种公式的吲哚和苯并咪唑15-脂氧化酶（15-LO）抑制剂，其中Y1和Y2中的一个是CH、N或NH，另一个是R3包括H、卤素、HN2、COOH、烷基；R4包括卤素、烷基和烷氧基；Z是C、CH或NR5；R5是H或氧羰基；每个X独立地是H、烷基、烷氧基或卤素。